Related Experiment Video
Updated: Mar 9, 2026
07:56
Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
11.1K
[Neonatal arterial ischemic stroke: Review of the current guidelines]
E Saliba1, T Debillon2,
1Service de réanimation néonatale et pédiatrique, hôpital Clocheville, CHU de Tours, 49, boulevard Béranger, 37000 Tours, France; Inserm U930, université François-Rabelais de Tours, bâtiment Vialle, 10, boulevard Tonnellé, 37032 Tours, France.
Summary
Neonatal arterial ischemic stroke (NAIS) guidelines emphasize prompt diagnosis via MRI and EEG, immediate treatment of infections, and supportive care for seizures. Routine thrombophilia testing is not recommended, and anticoagulation is generally not advised for NAIS.
Area of Science:
- Neonatology
- Neurology
- Pediatrics
Background:
- Neonatal arterial ischemic stroke (NAIS) is a rare condition affecting approximately 1 in 5000 infants.
- Diagnosis, risk factors, treatment, and follow-up for NAIS remain areas with limited evidence-based guidelines.
- Current management primarily involves supportive care due to unknown pathophysiology.
Purpose of the Study:
- To establish evidence-based guidelines for the diagnosis, management, and follow-up of NAIS.
- To address critical questions regarding risk factors and treatment strategies for NAIS.
- To provide a framework for healthcare professionals managing infants with NAIS.
Main Methods:
- Development of guidelines by a French national committee using Haute Autorité de santé (HAS) methodology.
- Review of risk factors, diagnostic modalities (MRI, continuous video EEG), and treatment options.
- Assessment of thrombophilia testing, anticoagulation, and long-term follow-up recommendations.
Main Results:
- Identified key risk factors: male sex, primiparity, C-section, perinatal hypoxia, and neonatal infection.
- Recommended MRI with diffusion-weighted imaging for diagnosis and continuous video EEG for monitoring.
- Advised against routine thrombophilia testing and anticoagulation, except in specific high-risk cases.
- Emphasized immediate treatment of infections/life-threatening conditions and phenobarbital for persistent seizures.
- Highlighted the low 5-year recurrence rate (1%) for NAIS.
- Recommended early multidisciplinary rehabilitation and ongoing neurodevelopmental follow-up.
Conclusions:
- Established comprehensive guidelines for NAIS diagnosis, treatment, and follow-up.
- Emphasized the importance of advanced imaging (MRI) and neurophysiological monitoring.
- Recommended a cautious approach to thrombophilia testing and anticoagulation.
- Stressed the need for early intervention and long-term monitoring for neurodevelopmental outcomes.
